Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictor' kit for aGvHD risk prediction
NCT02751112Terminated
- Sponsor
- Institut Imagine
- Start
- Nov 2015
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut Imagine. Primary endpoint: Assessment of the diagnosis test performance at 6 months. Started Nov 2015; status: terminated.
Beyond the preview
Go deeper on NCT02751112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02751112.